IMMUNOMODULATORY ROLE OF KERATIN 76 IN ORAL AND GASTRIC CANCER
I. Sequeira, J. F. Neves, D. Carrero, Q. Peng, N. Palasz, K. Liakath-Ali, G. Lord, P. R. Morgan, G. Lombardi, F. M. Watt
Abstract
Keratin 76 (Krt76) is expressed in the differentiated epithelial layers of skin, oral cavity and squamous stomach. Krt76 downregulation in human oral squamous cell carcinomas (OSCC) correlates with poor prognosis. We show that genetic ablation of Krt76 in mice leads to spleen and lymph node enlargement, an increase in regulatory T cells (Tregs) and high levels of pro-inflammatory cytokines. Krt76-/- Tregs have increased suppressive ability correlated with increased CD39 and CD73 expression, while their effector T cells are less proliferative than controls. Loss of Krt76 increases carcinogen-induced tumours in tongue and squamous stomach. Carcinogenesis is further increased when Treg levels are elevated experimentally. The carcinogenesis response includes upregulation of pro-inflammatory cytokines and enhanced accumulation of Tregs in the tumour microenvironment. Tregs also accumulate in human OSCC exhibiting Krt76 loss. Our study highlights the role of epithelial cells in modulating carcinogenesis via communication with cells of the immune system.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glucocorticoid receptor activation reprograms NK cells to drive AREG-mediated immunosuppression in skin cancer
- Extracellular prostaglandins E1 and E2 and inflammatory cytokines are regulated by the senescence program in potentially premalignant oral keratinocytes
L. P. Karen-Ng, U. S. Ahmad, … E. Parkinson·bioRxiv·Mar 10, 2022
- AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression.
K. Sakamoto, C. T. K. Nguyen, … A. Yamaguchi·bioRxiv·Sep 6, 2019
- ITGB6 inhibition stimulates anti-tumor responses in immunocompetent mouse models of head & neck squamous cell carcinoma and pancreatic adenocarcinoma
William J. MacDonald, Praveen R. Srinivasan, … Wafik S. El‐Deiry·bioRxiv·Apr 18, 2024
- KMT2D Loss Promotes Head and Neck Squamous Cell Carcinoma Through Enhancer Reprogramming and Modulation of Immune Microenvironment
S. C. Callahan, M. Divenko, … K. Rai·bioRxiv·Sep 21, 2021
- Bcl6 Preserves the Suppressive Function of Regulatory T Cells during Tumorigenesis
Y. Li, Z. Wang, … L. Xu·Frontiers in ImmunologyPeer-reviewed·May 12, 2020